Clinical Trial Update: Anti-CEA CAR-T for Advanced CEA-Positive Lung Carcinoma [Phase 1]

View source ↗

Summary

Phase 1 trial update of anti-CEA CAR-T therapy for advanced CEA-positive lung carcinoma; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Drugs mentioned

• Anti-CEA CAR-T (CEA-targeted CAR-T cells)

Snippet

Sponsor: Chongqing Precision Biotech Co., Ltd | Conditions: Advanced Lung Cancer | Phase 1 | Status: RECRUITING